[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Antineoplastic Agents Market - Global Outlook and Forecast 2021-2027

April 2021 | 105 pages | ID: A059E0F1AA4FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Antineoplastic Agents in Global, including the following market information:

Global Antineoplastic Agents Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Antineoplastic Agents market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antineoplastic Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antineoplastic Agents Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Antineoplastic Agents Market Segment Percentages, By Type, 2020 (%)
  • by Treatment Means
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
    • Hormonal Therapy (Biologic Therapy)
    • Others
  • by Dosage Form
    • Injection
    • Tablets
    • Capsule
    • Suppository
    • Granules
    • Implant
    • ??
  • by Nature of the Drug
    • Pharmaceutical Chemicals
    • Biological Medicine
    • Natural Product
China Antineoplastic Agents Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Antineoplastic Agents Market Segment Percentages, By Application, 2020 (%)
  • Plant Medicine
  • Hormone
  • Platinum Compounds
  • Metabolism Of Drug Resistance
  • Targeting Small Molecules
  • Drugs For Cancer
  • Antibiotic
  • Alkylating Agent
  • Chemoradiotherapy Protectant
  • Other
Global Antineoplastic Agents Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Antineoplastic Agents Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Antineoplastic Agents Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Antineoplastic Agents Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • BMS
  • MSD
  • Johnson & Johnson
  • Pfizer
  • AstraZeneca
  • Novartis
  • Sanofi
  • Celgene
  • Roche
  • Lilly
  • Bayer
  • Abraxis
  • Gilead
  • Wto-Day Order Pharmaceutical
  • Sinopharm
  • Shandong Lvye Pharmaceutical
  • CTTQ
  • Jiangsu Hengrui Pharmaceutical
  • Qilu Pharmaceutical
  • Baekdu Mountain Pharmaceutical
  • Baida Pharmaceutical
  • Jiangsu Haosen Pharmaceutical Group
  • Hainan Chang'an International Pharmaceutical
  • Zhejiang Kanglaite Pharmaceutical
  • Shandong New Era Pharmaceutical
  • Liaoning Novino Pharmaceutical
  • Maanshan Fengyuan Pharmaceutical
  • Meiluo Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Zhejiang Yatai Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antineoplastic Agents Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antineoplastic Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTINEOPLASTIC AGENTS OVERALL MARKET SIZE

2.1 Global Antineoplastic Agents Market Size: 2021 VS 2027
2.2 Global Antineoplastic Agents Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antineoplastic Agents Players in Global Market
3.2 Top Global Antineoplastic Agents Companies Ranked by Revenue
3.3 Global Antineoplastic Agents Revenue by Companies
3.4 Top 3 and Top 5 Antineoplastic Agents Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antineoplastic Agents Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antineoplastic Agents Players in Global Market
  3.6.1 List of Global Tier 1 Antineoplastic Agents Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antineoplastic Agents Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antineoplastic Agents Market Size Markets, 2021 & 2027
  4.1.2 Chemotherapy
  4.1.3 Targeted Therapy
  4.1.4 Immunotherapy
  4.1.5 Hormonal Therapy (Biologic Therapy)
  4.1.6 Others
4.2 By Type - Global Antineoplastic Agents Revenue & Forecasts
  4.2.1 By Type - Global Antineoplastic Agents Revenue, 2016-2021
  4.2.2 By Type - Global Antineoplastic Agents Revenue, 2022-2027
  4.2.3 By Type - Global Antineoplastic Agents Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antineoplastic Agents Market Size, 2021 & 2027
  5.1.2 Plant Medicine
  5.1.3 Hormone
  5.1.4 Platinum Compounds
  5.1.5 Metabolism Of Drug Resistance
  5.1.6 Targeting Small Molecules
  5.1.7 Drugs For Cancer
  5.1.8 Antibiotic
  5.1.9 Alkylating Agent
  5.1.10 Chemoradiotherapy Protectant
  5.1.11 Other
5.2 By Application - Global Antineoplastic Agents Revenue & Forecasts
  5.2.1 By Application - Global Antineoplastic Agents Revenue, 2016-2021
  5.2.2 By Application - Global Antineoplastic Agents Revenue, 2022-2027
  5.2.3 By Application - Global Antineoplastic Agents Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antineoplastic Agents Market Size, 2021 & 2027
6.2 By Region - Global Antineoplastic Agents Revenue & Forecasts
  6.2.1 By Region - Global Antineoplastic Agents Revenue, 2016-2021
  6.2.2 By Region - Global Antineoplastic Agents Revenue, 2022-2027
  6.2.3 By Region - Global Antineoplastic Agents Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Antineoplastic Agents Revenue, 2016-2027
  6.3.2 US Antineoplastic Agents Market Size, 2016-2027
  6.3.3 Canada Antineoplastic Agents Market Size, 2016-2027
  6.3.4 Mexico Antineoplastic Agents Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Antineoplastic Agents Revenue, 2016-2027
  6.4.2 Germany Antineoplastic Agents Market Size, 2016-2027
  6.4.3 France Antineoplastic Agents Market Size, 2016-2027
  6.4.4 U.K. Antineoplastic Agents Market Size, 2016-2027
  6.4.5 Italy Antineoplastic Agents Market Size, 2016-2027
  6.4.6 Russia Antineoplastic Agents Market Size, 2016-2027
  6.4.7 Nordic Countries Antineoplastic Agents Market Size, 2016-2027
  6.4.8 Benelux Antineoplastic Agents Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Antineoplastic Agents Revenue, 2016-2027
  6.5.2 China Antineoplastic Agents Market Size, 2016-2027
  6.5.3 Japan Antineoplastic Agents Market Size, 2016-2027
  6.5.4 South Korea Antineoplastic Agents Market Size, 2016-2027
  6.5.5 Southeast Asia Antineoplastic Agents Market Size, 2016-2027
  6.5.6 India Antineoplastic Agents Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Antineoplastic Agents Revenue, 2016-2027
  6.6.2 Brazil Antineoplastic Agents Market Size, 2016-2027
  6.6.3 Argentina Antineoplastic Agents Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antineoplastic Agents Revenue, 2016-2027
  6.7.2 Turkey Antineoplastic Agents Market Size, 2016-2027
  6.7.3 Israel Antineoplastic Agents Market Size, 2016-2027
  6.7.4 Saudi Arabia Antineoplastic Agents Market Size, 2016-2027
  6.7.5 UAE Antineoplastic Agents Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 BMS
  7.1.1 BMS Corporate Summary
  7.1.2 BMS Business Overview
  7.1.3 BMS Antineoplastic Agents Major Product Offerings
  7.1.4 BMS Antineoplastic Agents Revenue in Global (2016-2021)
  7.1.5 BMS Key News
7.2 MSD
  7.2.1 MSD Corporate Summary
  7.2.2 MSD Business Overview
  7.2.3 MSD Antineoplastic Agents Major Product Offerings
  7.2.4 MSD Antineoplastic Agents Revenue in Global (2016-2021)
  7.2.5 MSD Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Antineoplastic Agents Major Product Offerings
  7.3.4 Johnson & Johnson Antineoplastic Agents Revenue in Global (2016-2021)
  7.3.5 Johnson & Johnson Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Antineoplastic Agents Major Product Offerings
  7.4.4 Pfizer Antineoplastic Agents Revenue in Global (2016-2021)
  7.4.5 Pfizer Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Antineoplastic Agents Major Product Offerings
  7.5.4 AstraZeneca Antineoplastic Agents Revenue in Global (2016-2021)
  7.5.5 AstraZeneca Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Antineoplastic Agents Major Product Offerings
  7.6.4 Novartis Antineoplastic Agents Revenue in Global (2016-2021)
  7.6.5 Novartis Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Antineoplastic Agents Major Product Offerings
  7.4.4 Sanofi Antineoplastic Agents Revenue in Global (2016-2021)
  7.7.5 Sanofi Key News
7.8 Celgene
  7.8.1 Celgene Corporate Summary
  7.8.2 Celgene Business Overview
  7.8.3 Celgene Antineoplastic Agents Major Product Offerings
  7.8.4 Celgene Antineoplastic Agents Revenue in Global (2016-2021)
  7.8.5 Celgene Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Antineoplastic Agents Major Product Offerings
  7.9.4 Roche Antineoplastic Agents Revenue in Global (2016-2021)
  7.9.5 Roche Key News
7.10 Lilly
  7.10.1 Lilly Corporate Summary
  7.10.2 Lilly Business Overview
  7.10.3 Lilly Antineoplastic Agents Major Product Offerings
  7.10.4 Lilly Antineoplastic Agents Revenue in Global (2016-2021)
  7.10.5 Lilly Key News
7.11 Bayer
  7.11.1 Bayer Corporate Summary
  7.11.2 Bayer Business Overview
  7.11.3 Bayer Antineoplastic Agents Major Product Offerings
  7.11.4 Bayer Antineoplastic Agents Revenue in Global (2016-2021)
  7.11.5 Bayer Key News
7.12 Abraxis
  7.12.1 Abraxis Corporate Summary
  7.12.2 Abraxis Business Overview
  7.12.3 Abraxis Antineoplastic Agents Major Product Offerings
  7.12.4 Abraxis Antineoplastic Agents Revenue in Global (2016-2021)
  7.12.5 Abraxis Key News
7.13 Gilead
  7.13.1 Gilead Corporate Summary
  7.13.2 Gilead Business Overview
  7.13.3 Gilead Antineoplastic Agents Major Product Offerings
  7.13.4 Gilead Antineoplastic Agents Revenue in Global (2016-2021)
  7.13.5 Gilead Key News
7.14 Wto-Day Order Pharmaceutical
  7.14.1 Wto-Day Order Pharmaceutical Corporate Summary
  7.14.2 Wto-Day Order Pharmaceutical Business Overview
  7.14.3 Wto-Day Order Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.14.4 Wto-Day Order Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.14.5 Wto-Day Order Pharmaceutical Key News
7.15 Sinopharm
  7.15.1 Sinopharm Corporate Summary
  7.15.2 Sinopharm Business Overview
  7.15.3 Sinopharm Antineoplastic Agents Major Product Offerings
  7.15.4 Sinopharm Antineoplastic Agents Revenue in Global (2016-2021)
  7.15.5 Sinopharm Key News
7.16 Shandong Lvye Pharmaceutical
  7.16.1 Shandong Lvye Pharmaceutical Corporate Summary
  7.16.2 Shandong Lvye Pharmaceutical Business Overview
  7.16.3 Shandong Lvye Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.16.4 Shandong Lvye Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.16.5 Shandong Lvye Pharmaceutical Key News
7.17 CTTQ
  7.17.1 CTTQ Corporate Summary
  7.17.2 CTTQ Business Overview
  7.17.3 CTTQ Antineoplastic Agents Major Product Offerings
  7.17.4 CTTQ Antineoplastic Agents Revenue in Global (2016-2021)
  7.17.5 CTTQ Key News
7.18 Jiangsu Hengrui Pharmaceutical
  7.18.1 Jiangsu Hengrui Pharmaceutical Corporate Summary
  7.18.2 Jiangsu Hengrui Pharmaceutical Business Overview
  7.18.3 Jiangsu Hengrui Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.18.4 Jiangsu Hengrui Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.18.5 Jiangsu Hengrui Pharmaceutical Key News
7.19 Qilu Pharmaceutical
  7.19.1 Qilu Pharmaceutical Corporate Summary
  7.19.2 Qilu Pharmaceutical Business Overview
  7.19.3 Qilu Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.19.4 Qilu Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.19.5 Qilu Pharmaceutical Key News
7.20 Baekdu Mountain Pharmaceutical
  7.20.1 Baekdu Mountain Pharmaceutical Corporate Summary
  7.20.2 Baekdu Mountain Pharmaceutical Business Overview
  7.20.3 Baekdu Mountain Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.20.4 Baekdu Mountain Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.20.5 Baekdu Mountain Pharmaceutical Key News
7.21 Baida Pharmaceutical
  7.21.1 Baida Pharmaceutical Corporate Summary
  7.21.2 Baida Pharmaceutical Business Overview
  7.21.3 Baida Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.21.4 Baida Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.21.5 Baida Pharmaceutical Key News
7.22 Jiangsu Haosen Pharmaceutical Group
  7.22.1 Jiangsu Haosen Pharmaceutical Group Corporate Summary
  7.22.2 Jiangsu Haosen Pharmaceutical Group Business Overview
  7.22.3 Jiangsu Haosen Pharmaceutical Group Antineoplastic Agents Major Product Offerings
  7.22.4 Jiangsu Haosen Pharmaceutical Group Antineoplastic Agents Revenue in Global (2016-2021)
  7.22.5 Jiangsu Haosen Pharmaceutical Group Key News
7.23 Hainan Chang'an International Pharmaceutical
  7.23.1 Hainan Chang'an International Pharmaceutical Corporate Summary
  7.23.2 Hainan Chang'an International Pharmaceutical Business Overview
  7.23.3 Hainan Chang'an International Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.23.4 Hainan Chang'an International Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.23.5 Hainan Chang'an International Pharmaceutical Key News
7.24 Zhejiang Kanglaite Pharmaceutical
  7.24.1 Zhejiang Kanglaite Pharmaceutical Corporate Summary
  7.24.2 Zhejiang Kanglaite Pharmaceutical Business Overview
  7.24.3 Zhejiang Kanglaite Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.24.4 Zhejiang Kanglaite Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.24.5 Zhejiang Kanglaite Pharmaceutical Key News
7.25 Shandong New Era Pharmaceutical
  7.25.1 Shandong New Era Pharmaceutical Corporate Summary
  7.25.2 Shandong New Era Pharmaceutical Business Overview
  7.25.3 Shandong New Era Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.25.4 Shandong New Era Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.25.5 Shandong New Era Pharmaceutical Key News
7.26 Liaoning Novino Pharmaceutical
  7.26.1 Liaoning Novino Pharmaceutical Corporate Summary
  7.26.2 Liaoning Novino Pharmaceutical Business Overview
  7.26.3 Liaoning Novino Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.26.4 Liaoning Novino Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.26.5 Liaoning Novino Pharmaceutical Key News
7.27 Maanshan Fengyuan Pharmaceutical
  7.27.1 Maanshan Fengyuan Pharmaceutical Corporate Summary
  7.27.2 Maanshan Fengyuan Pharmaceutical Business Overview
  7.27.3 Maanshan Fengyuan Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.27.4 Maanshan Fengyuan Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.27.5 Maanshan Fengyuan Pharmaceutical Key News
7.28 Meiluo Pharmaceutical
  7.28.1 Meiluo Pharmaceutical Corporate Summary
  7.28.2 Meiluo Pharmaceutical Business Overview
  7.28.3 Meiluo Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.28.4 Meiluo Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.28.5 Meiluo Pharmaceutical Key News
7.29 Shandong Luoxin Pharmaceutical Group
  7.29.1 Shandong Luoxin Pharmaceutical Group Corporate Summary
  7.29.2 Shandong Luoxin Pharmaceutical Group Business Overview
  7.29.3 Shandong Luoxin Pharmaceutical Group Antineoplastic Agents Major Product Offerings
  7.29.4 Shandong Luoxin Pharmaceutical Group Antineoplastic Agents Revenue in Global (2016-2021)
  7.29.5 Shandong Luoxin Pharmaceutical Group Key News
7.30 Zhejiang Yatai Pharmaceutical
  7.30.1 Zhejiang Yatai Pharmaceutical Corporate Summary
  7.30.2 Zhejiang Yatai Pharmaceutical Business Overview
  7.30.3 Zhejiang Yatai Pharmaceutical Antineoplastic Agents Major Product Offerings
  7.30.4 Zhejiang Yatai Pharmaceutical Antineoplastic Agents Revenue in Global (2016-2021)
  7.30.5 Zhejiang Yatai Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Antineoplastic Agents Market Opportunities & Trends in Global Market
Table 2. Antineoplastic Agents Market Drivers in Global Market
Table 3. Antineoplastic Agents Market Restraints in Global Market
Table 4. Key Players of Antineoplastic Agents in Global Market
Table 5. Top Antineoplastic Agents Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Antineoplastic Agents Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Antineoplastic Agents Revenue Share by Companies, 2016-2021
Table 8. Global Companies Antineoplastic Agents Product Type
Table 9. List of Global Tier 1 Antineoplastic Agents Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antineoplastic Agents Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Antineoplastic Agents Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Antineoplastic Agents Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Antineoplastic Agents Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Antineoplastic Agents Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Antineoplastic Agents Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Antineoplastic Agents Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Antineoplastic Agents Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Antineoplastic Agents Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Antineoplastic Agents Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Antineoplastic Agents Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Antineoplastic Agents Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Antineoplastic Agents Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Antineoplastic Agents Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Antineoplastic Agents Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Antineoplastic Agents Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Antineoplastic Agents Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Antineoplastic Agents Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Antineoplastic Agents Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Antineoplastic Agents Revenue, (US$, Mn), 2022-2027
Table 30. BMS Corporate Summary
Table 31. BMS Antineoplastic Agents Product Offerings
Table 32. BMS Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 33. MSD Corporate Summary
Table 34. MSD Antineoplastic Agents Product Offerings
Table 35. MSD Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Antineoplastic Agents Product Offerings
Table 38. Johnson & Johnson Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Antineoplastic Agents Product Offerings
Table 41. Pfizer Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Antineoplastic Agents Product Offerings
Table 44. AstraZeneca Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 45. Novartis Corporate Summary
Table 46. Novartis Antineoplastic Agents Product Offerings
Table 47. Novartis Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Antineoplastic Agents Product Offerings
Table 50. Sanofi Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 51. Celgene Corporate Summary
Table 52. Celgene Antineoplastic Agents Product Offerings
Table 53. Celgene Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 54. Roche Corporate Summary
Table 55. Roche Antineoplastic Agents Product Offerings
Table 56. Roche Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 57. Lilly Corporate Summary
Table 58. Lilly Antineoplastic Agents Product Offerings
Table 59. Lilly Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 60. Bayer Corporate Summary
Table 61. Bayer Antineoplastic Agents Product Offerings
Table 62. Bayer Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 63. Abraxis Corporate Summary
Table 64. Abraxis Antineoplastic Agents Product Offerings
Table 65. Abraxis Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 66. Gilead Corporate Summary
Table 67. Gilead Antineoplastic Agents Product Offerings
Table 68. Gilead Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 69. Wto-Day Order Pharmaceutical Corporate Summary
Table 70. Wto-Day Order Pharmaceutical Antineoplastic Agents Product Offerings
Table 71. Wto-Day Order Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 72. Sinopharm Corporate Summary
Table 73. Sinopharm Antineoplastic Agents Product Offerings
Table 74. Sinopharm Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 75. Shandong Lvye Pharmaceutical Corporate Summary
Table 76. Shandong Lvye Pharmaceutical Antineoplastic Agents Product Offerings
Table 77. Shandong Lvye Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 78. CTTQ Corporate Summary
Table 79. CTTQ Antineoplastic Agents Product Offerings
Table 80. CTTQ Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 81. Jiangsu Hengrui Pharmaceutical Corporate Summary
Table 82. Jiangsu Hengrui Pharmaceutical Antineoplastic Agents Product Offerings
Table 83. Jiangsu Hengrui Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 84. Qilu Pharmaceutical Corporate Summary
Table 85. Qilu Pharmaceutical Antineoplastic Agents Product Offerings
Table 86. Qilu Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 87. Baekdu Mountain Pharmaceutical Corporate Summary
Table 88. Baekdu Mountain Pharmaceutical Antineoplastic Agents Product Offerings
Table 89. Baekdu Mountain Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 90. Baida Pharmaceutical Corporate Summary
Table 91. Baida Pharmaceutical Antineoplastic Agents Product Offerings
Table 92. Baida Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 93. Jiangsu Haosen Pharmaceutical Group Corporate Summary
Table 94. Jiangsu Haosen Pharmaceutical Group Antineoplastic Agents Product Offerings
Table 95. Jiangsu Haosen Pharmaceutical Group Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 96. Hainan Chang'an International Pharmaceutical Corporate Summary
Table 97. Hainan Chang'an International Pharmaceutical Antineoplastic Agents Product Offerings
Table 98. Hainan Chang'an International Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 99. Zhejiang Kanglaite Pharmaceutical Corporate Summary
Table 100. Zhejiang Kanglaite Pharmaceutical Antineoplastic Agents Product Offerings
Table 101. Zhejiang Kanglaite Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 102. Shandong New Era Pharmaceutical Corporate Summary
Table 103. Shandong New Era Pharmaceutical Antineoplastic Agents Product Offerings
Table 104. Shandong New Era Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 105. Liaoning Novino Pharmaceutical Corporate Summary
Table 106. Liaoning Novino Pharmaceutical Antineoplastic Agents Product Offerings
Table 107. Liaoning Novino Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 108. Maanshan Fengyuan Pharmaceutical Corporate Summary
Table 109. Maanshan Fengyuan Pharmaceutical Antineoplastic Agents Product Offerings
Table 110. Maanshan Fengyuan Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 111. Meiluo Pharmaceutical Corporate Summary
Table 112. Meiluo Pharmaceutical Antineoplastic Agents Product Offerings
Table 113. Meiluo Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 114. Shandong Luoxin Pharmaceutical Group Corporate Summary
Table 115. Shandong Luoxin Pharmaceutical Group Antineoplastic Agents Product Offerings
Table 116. Shandong Luoxin Pharmaceutical Group Antineoplastic Agents Revenue (US$, Mn), (2016-2021)
Table 117. Zhejiang Yatai Pharmaceutical Corporate Summary
Table 118. Zhejiang Yatai Pharmaceutical Antineoplastic Agents Product Offerings
Table 119. Zhejiang Yatai Pharmaceutical Antineoplastic Agents Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Antineoplastic Agents Segment by Type
Figure 2. Antineoplastic Agents Segment by Application
Figure 3. Global Antineoplastic Agents Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antineoplastic Agents Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Antineoplastic Agents Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antineoplastic Agents Revenue in 2020
Figure 8. By Type - Global Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 9. By Application - Global Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 10. By Region - Global Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 11. By Country - North America Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 12. US Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 16. Germany Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 17. France Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 24. China Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 28. India Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 30. Brazil Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Antineoplastic Agents Revenue Market Share, 2016-2027
Figure 33. Turkey Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Antineoplastic Agents Revenue, (US$, Mn), 2016-2027
Figure 37. BMS Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. MSD Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Johnson & Johnson Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pfizer Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Novartis Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Sanofi Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Celgene Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Roche Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lilly Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Bayer Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Abraxis Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Gilead Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Wto-Day Order Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Sinopharm Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Shandong Lvye Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. CTTQ Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Jiangsu Hengrui Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Qilu Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Baekdu Mountain Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Baida Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Jiangsu Haosen Pharmaceutical Group Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Hainan Chang'an International Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Zhejiang Kanglaite Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Shandong New Era Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 62. Liaoning Novino Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 63. Maanshan Fengyuan Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 64. Meiluo Pharmaceutical Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 65. Shandong Luoxin Pharmaceutical Group Antineoplastic Agents Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications